Hsa_circ_0030586 promotes epithelial–mesenchymal transition in prostate cancer via PI3K-AKT signaling

References

• Kimura T, Egawa S. Epidemiology of prostate cancer in Asian countries. Int J Urol. 2018;25(6):524–531.
   PubMed Web of Science ®Google Scholar
• Pernar CH, Ebot EM, Wilson KM, et al. The epidemiology of prostate cancer. Cold Spring Harb Perspect Med. 2018;8(12):a030361.
   PubMed Web of Science ®Google Scholar
• Sartor O, de Bono JS, Longo DL. Metastatic prostate cancer. N Engl J Med. 2018;378(7):645–657.
   PubMed Web of Science ®Google Scholar
• May EJ, Viers LD, Viers BR, et al. Prostate cancer post-treatment follow-up and recurrence evaluation. Abdom Radiol (NY). 2016;41(5):862–876.
   PubMed Web of Science ®Google Scholar
• Evans AJ. Treatment effects in prostate cancer. Mod Pathol. 2018;31(S1):S110–121.
   PubMedGoogle Scholar
• Ng WL, Mohd Mohidin TB, Shukla K. Functional role of circular RNAs in cancer development and progression. RNA Biol. 2018;15(8):995–1005.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang J, Khanabdali R, et al. Circular RNAs: isolation, characterization and their potential role in diseases. RNA Biol. 2017;14(12):1715–1721.
   PubMed Web of Science ®Google Scholar
• Shabaninejad Z, Vafadar A, Movahedpour A, et al. Circular RNAs in cancer: new insights into functions and implications in ovarian cancer. J Ovarian Res. 2019;12(1):84.
   PubMed Web of Science ®Google Scholar
• Cai F, Li J, Zhang J, et al. Knockdown of circ_CCNB2 sensitizes prostate cancer to radiation through repressing autophagy by the miR-30b-5p/KIF18A axis. Cancer Biother Radiopharm. 2020. DOI:10.1089/cbr.2019.3538
   Web of Science ®Google Scholar
• Gao Y, Liu J, Huan J, et al. Downregulation of circular RNA hsa_circ_0000735 boosts prostate cancer sensitivity to docetaxel via sponging miR-7. Cancer Cell Int. 2020;20:334.
   PubMed Web of Science ®Google Scholar
• Weng XD, Yan T, Liu CL. Circular RNA_LARP4 inhibits cell migration and invasion of prostate cancer by targeting FOXO3A. Eur Rev Med Pharmacol Sci. 2020;24(10):5303–5309.
   PubMed Web of Science ®Google Scholar
• Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869–881.e813.
   PubMed Web of Science ®Google Scholar
• Kong Z, Wan X, Lu Y, et al. Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR-29a-3p. J Cell Mol Med. 2020;24(1):799–813.
   PubMed Web of Science ®Google Scholar
• Shi J, Liu C, Chen C, et al. Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis. Aging (Albany NY). 2020;12(13):13255–13280.
   PubMedGoogle Scholar
• Matin F, Jeet V, Moya L, et al. A plasma biomarker panel of four microRNAs for the diagnosis of prostate cancer. Sci Rep. 2018;8(1):6653.
   PubMedGoogle Scholar
• He JH, Zhang JZ, Han ZP, et al. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells. J Exp Clin Cancer Res. 2014;33(1):72.
   PubMedGoogle Scholar
• He JH, Han ZP, Zhou JB, et al. MiR-145 affected the circular RNA expression in prostate cancer LNCaP cells. J Cell Biochem. 2018;119(11):9168–9177.
   PubMed Web of Science ®Google Scholar
• Ma Y, Ren Y, and Wen H, et al. CircCOL1A1 promotes the progression of gastric cancer cells through sponging miR-145 to enhance RABL3 expression. J ImmunolRes. 2021;2021:6724854.
   Google Scholar
• Pan D, Jia Z, Li W, et al. The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells. Int J Oncol. 2019;54(6):1955–1968.
   PubMed Web of Science ®Google Scholar
• Goto Y, Kurozumi A, Arai T, et al. Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer. Br J Cancer. 2017;117(3):409–420.
   PubMed Web of Science ®Google Scholar
• Coarfa C, Fiskus W, Eedunuri VK, et al. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer. Oncogene. 2016;35(18):2345–2356.
   PubMed Web of Science ®Google Scholar
• Chen W, Yao G, and Zhou K. MiR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7. J CellBiochem. 2019;120(8):14055–14064.
   Google Scholar
• Lu YT, Delijani K, Mecum A, et al. Current status of liquid biopsies for the detection and management of prostate cancer. Cancer Manag Res. 2019;11:5271–5291.
   PubMed Web of Science ®Google Scholar
• Bozkurt S, Paul R, Coquet J, et al. Phenotyping severity of patient-centered outcomes using clinical notes: a prostate cancer use case. Learn Health Syst. 2020;4(4):e10237.
   PubMed Web of Science ®Google Scholar
• Lachance J. Beyond stamp collecting: evolutionary and functional genomics advance our understanding of cancer biology. Cancer Res. 2021;81(7):1637–1638.
   PubMed Web of Science ®Google Scholar
• Mokou M, Frantzi M, Mischak H, et al. Developing novel drug candidates and repurposed drugs for prostate cancer based on molecular profiles. Curr Med Chem. 2021;28. DOI:10.2174/0929867328666210525162730
   PubMed Web of Science ®Google Scholar
• Chen S, Huang V, Xu X, et al. Widespread and functional RNA circularization in localized prostate cancer. Cell. 2019;176(4):831–843.e822.
   PubMed Web of Science ®Google Scholar
• Li T, Sun X, Chen L. Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker. J Cell Biochem. 2020;121(3):2118–2126.
   PubMed Web of Science ®Google Scholar
• Greene J, Baird AM, Casey O, et al. Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide. Sci Rep. 2019;9(1):10739.
   PubMed Web of Science ®Google Scholar
• Feng Y, Yang Y, Zhao X, et al. Circular RNA circ0005276 promotes the proliferation and migration of prostate cancer cells by interacting with FUS to transcriptionally activate XIAP. Cell Death Dis. 2019;10(11):792.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Chen CJ, Lin ZY, et al. Circ_KATNAL1 regulates prostate cancer cell growth and invasiveness through the miR-145-3p/WISP1 pathway. Biochem Cell Biol. 2020;98(3):396–404.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang L, Yin S, et al. Hsa_circ_0062019 promotes the proliferation, migration, and invasion of prostate cancer cells via the miR-195-5p/HMGA2 axis. Acta Biochim Biophys Sin (Shanghai). 2021;53:815–822.
   PubMed Web of Science ®Google Scholar
• Li X, Azhati B, Wang W, et al. Circular RNA UBAP2 promotes the proliferation of prostate cancer cells via the miR-1244/MAP3K2 axis. Oncol Lett. 2021;21(6):486.
   PubMed Web of Science ®Google Scholar
• Chen W, Cen S, Zhou X, et al. Circular RNA circNOLC1, upregulated by NF-KappaB, promotes the progression of prostate cancer via miR-647/PAQR4 axis. Front Cell Dev Biol. 2020;8:624764.
   PubMed Web of Science ®Google Scholar
• Sha J, Xia L, Han Q, et al. Downregulation of circ-TRPS1 suppressed prostatic cancer prognoses by regulating miR-124-3p/EZH2 axis-mediated stemness. Am J Cancer Res. 2020;10(12):4372–4385.
   PubMed Web of Science ®Google Scholar
• Nan C, Wang Y, Yang S, et al. CircCRKL suppresses the progression of prostate cancer cells by regulating the miR-141/KLF5 axis. Pathol Res Pract. 2020;216(11):153182.
   PubMed Web of Science ®Google Scholar
• Xiang Z, Xu C, Wu G, et al. CircRNA-UCK2 increased TET1 inhibits proliferation and invasion of prostate cancer cells via sponge MiRNA-767-5p. Open Med (Wars). 2019;14:833–842.
   PubMedGoogle Scholar
• Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125–1134.
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang J, Zheng Y, et al. Comprehensive identification of internal structure and alternative splicing events in circular RNAs. Nat Commun. 2016;7:12060.
   PubMed Web of Science ®Google Scholar
• Liu F, Fan Y, Ou L, et al. CircHIPK3 facilitates the G2/M transition in prostate cancer cells by sponging miR-338-3p. Onco Targets Ther. 2020;13:4545–4558.
   PubMed Web of Science ®Google Scholar
• Shan G, Shao B, Liu Q, et al. CircFMN2 sponges miR-1238 to promote the expression of LIM-Homeobox Gene 2 in prostate cancer cells. Mol Ther Nucleic Acids. 2020;21:133–146.
   PubMedGoogle Scholar
• Zhu Q, Youn H, Tang J, et al. Phosphoinositide 3-OH kinase p85alpha and p110beta are essential for androgen receptor transactivation and tumor progression in prostate cancers. Oncogene. 2008;27(33):4569–4579.
   PubMed Web of Science ®Google Scholar
• Berenjeno IM, Guillermet-Guibert J, Pearce W, et al. Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor. Biochem J. 2012;442(1):151–159.
   PubMedGoogle Scholar
• He C, Duan S, Dong L, et al. Characterization of a novel p110β-specific inhibitor BL140 that overcomes MDV3100-resistance in castration-resistant prostate cancer cells. Prostate. 2017;77(11):1187–1198.
   PubMed Web of Science ®Google Scholar
• Sun W, Zu S, Shao G, et al. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway. J Gene Med. 2021;23(7):e3344.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang F, Xu H, et al. Long non-coding RNA SNHG1 regulates the Wnt/β-Catenin and PI3K/AKT/mTOR signaling pathways via EZH2 to affect the proliferation, apoptosis, and autophagy of prostate cancer cell. Front Oncol. 2020;10:552907.
   PubMed Web of Science ®Google Scholar